Back to search results

Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Pancreatic Adenocarcinoma · Metastatic Pancreatic Cancer · Basal Cell Neoplasm

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Catherine A Griffin) · catherine_griffin@med.unc.edu · 984-974-8771
    Contact: Principal Investigator (Ashwin Somasundaram, MD)
Study leads

  • Ashwin Somasundaram, MD

    Principal Investigator

    UNC Lineberger Comprehensive Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)